Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5497
Abstract: The CSCO and ASCO guidelines in 2021 recommend chemotherapy for stage III–IVA (8th edition of AJCC staging) nasopharyngeal carcinoma (NPC). Actually, patients with stage T3–4N0M0 are often excluded from various clinical trials of the locoregionally… read more here.
Keywords: nasopharyngeal carcinoma; advanced nasopharyngeal; locoregionally advanced; chemotherapy locoregionally ... See more keywords